- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.40 Å
- Oligo State
- homo-octamer
- Ligands
- 16 x NAG- NAG- FUL: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[beta-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 8 x GLY: GLYCINE(Non-covalent)
GLY.3: 5 residues within 4Å:- Chain A: L.16, Y.59, W.96, D.127, K.129
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:W.96
- Water bridges: A:K.129
- Salt bridges: A:K.129
GLY.21: 5 residues within 4Å:- Chain B: L.16, Y.59, W.96, D.127, K.129
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:W.96
- Water bridges: B:K.129
- Salt bridges: B:K.129
GLY.39: 5 residues within 4Å:- Chain C: L.16, Y.59, W.96, D.127, K.129
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:W.96
- Water bridges: C:K.129
- Salt bridges: C:K.129
GLY.57: 5 residues within 4Å:- Chain D: L.16, Y.59, W.96, D.127, K.129
3 PLIP interactions:3 interactions with chain D- Hydrogen bonds: D:W.96
- Water bridges: D:K.129
- Salt bridges: D:K.129
GLY.75: 5 residues within 4Å:- Chain E: L.16, Y.59, W.96, D.127, K.129
3 PLIP interactions:3 interactions with chain E- Hydrogen bonds: E:W.96
- Water bridges: E:K.129
- Salt bridges: E:K.129
GLY.93: 5 residues within 4Å:- Chain F: L.16, Y.59, W.96, D.127, K.129
3 PLIP interactions:3 interactions with chain F- Hydrogen bonds: F:W.96
- Water bridges: F:K.129
- Salt bridges: F:K.129
GLY.111: 5 residues within 4Å:- Chain G: L.16, Y.59, W.96, D.127, K.129
3 PLIP interactions:3 interactions with chain G- Hydrogen bonds: G:W.96
- Water bridges: G:K.129
- Salt bridges: G:K.129
GLY.129: 5 residues within 4Å:- Chain H: L.16, Y.59, W.96, D.127, K.129
3 PLIP interactions:3 interactions with chain H- Hydrogen bonds: H:W.96
- Water bridges: H:K.129
- Salt bridges: H:K.129
- 8 x VX: O-ETHYLMETHYLPHOSPHONIC ACID ESTER GROUP(Covalent)
VX.4: 10 residues within 4Å:- Chain A: G.113, G.114, G.115, S.196, A.197, W.229, L.284, V.286, H.436
- Ligands: MG.18
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:V.286
- Hydrogen bonds: A:G.114, A:G.115, A:A.197
VX.22: 10 residues within 4Å:- Chain B: G.113, G.114, G.115, S.196, A.197, W.229, L.284, V.286, H.436
- Ligands: MG.36
4 PLIP interactions:4 interactions with chain B- Hydrophobic interactions: B:V.286
- Hydrogen bonds: B:G.114, B:G.115, B:A.197
VX.40: 10 residues within 4Å:- Chain C: G.113, G.114, G.115, S.196, A.197, W.229, L.284, V.286, H.436
- Ligands: MG.54
4 PLIP interactions:4 interactions with chain C- Hydrophobic interactions: C:V.286
- Hydrogen bonds: C:G.114, C:G.115, C:A.197
VX.58: 10 residues within 4Å:- Chain D: G.113, G.114, G.115, S.196, A.197, W.229, L.284, V.286, H.436
- Ligands: MG.72
4 PLIP interactions:4 interactions with chain D- Hydrophobic interactions: D:V.286
- Hydrogen bonds: D:G.114, D:G.115, D:A.197
VX.76: 10 residues within 4Å:- Chain E: G.113, G.114, G.115, S.196, A.197, W.229, L.284, V.286, H.436
- Ligands: MG.90
4 PLIP interactions:4 interactions with chain E- Hydrophobic interactions: E:V.286
- Hydrogen bonds: E:G.114, E:G.115, E:A.197
VX.94: 10 residues within 4Å:- Chain F: G.113, G.114, G.115, S.196, A.197, W.229, L.284, V.286, H.436
- Ligands: MG.108
4 PLIP interactions:4 interactions with chain F- Hydrophobic interactions: F:V.286
- Hydrogen bonds: F:G.114, F:G.115, F:A.197
VX.112: 10 residues within 4Å:- Chain G: G.113, G.114, G.115, S.196, A.197, W.229, L.284, V.286, H.436
- Ligands: MG.126
4 PLIP interactions:4 interactions with chain G- Hydrophobic interactions: G:V.286
- Hydrogen bonds: G:G.114, G:G.115, G:A.197
VX.130: 10 residues within 4Å:- Chain H: G.113, G.114, G.115, S.196, A.197, W.229, L.284, V.286, H.436
- Ligands: MG.144
4 PLIP interactions:4 interactions with chain H- Hydrophobic interactions: H:V.286
- Hydrogen bonds: H:G.114, H:G.115, H:A.197
- 16 x SO4: SULFATE ION(Non-functional Binders)
SO4.5: 4 residues within 4Å:- Chain A: Q.314, G.411, N.412, N.413
Ligand excluded by PLIPSO4.6: 6 residues within 4Å:- Chain A: R.518, F.519, F.523
- Chain D: S.522, F.523
- Ligands: SO4.60
Ligand excluded by PLIPSO4.23: 4 residues within 4Å:- Chain B: Q.314, G.411, N.412, N.413
Ligand excluded by PLIPSO4.24: 6 residues within 4Å:- Chain B: R.518, F.519, F.523
- Chain C: S.522, F.523
- Ligands: SO4.42
Ligand excluded by PLIPSO4.41: 4 residues within 4Å:- Chain C: Q.314, G.411, N.412, N.413
Ligand excluded by PLIPSO4.42: 6 residues within 4Å:- Chain B: S.522, F.523
- Chain C: R.518, F.519, F.523
- Ligands: SO4.24
Ligand excluded by PLIPSO4.59: 4 residues within 4Å:- Chain D: Q.314, G.411, N.412, N.413
Ligand excluded by PLIPSO4.60: 6 residues within 4Å:- Chain A: S.522, F.523
- Chain D: R.518, F.519, F.523
- Ligands: SO4.6
Ligand excluded by PLIPSO4.77: 4 residues within 4Å:- Chain E: Q.314, G.411, N.412, N.413
Ligand excluded by PLIPSO4.78: 6 residues within 4Å:- Chain E: R.518, F.519, F.523
- Chain H: S.522, F.523
- Ligands: SO4.132
Ligand excluded by PLIPSO4.95: 4 residues within 4Å:- Chain F: Q.314, G.411, N.412, N.413
Ligand excluded by PLIPSO4.96: 6 residues within 4Å:- Chain F: R.518, F.519, F.523
- Chain G: S.522, F.523
- Ligands: SO4.114
Ligand excluded by PLIPSO4.113: 4 residues within 4Å:- Chain G: Q.314, G.411, N.412, N.413
Ligand excluded by PLIPSO4.114: 6 residues within 4Å:- Chain F: S.522, F.523
- Chain G: R.518, F.519, F.523
- Ligands: SO4.96
Ligand excluded by PLIPSO4.131: 4 residues within 4Å:- Chain H: Q.314, G.411, N.412, N.413
Ligand excluded by PLIPSO4.132: 6 residues within 4Å:- Chain E: S.522, F.523
- Chain H: R.518, F.519, F.523
- Ligands: SO4.78
Ligand excluded by PLIP- 16 x NA: SODIUM ION(Non-functional Binders)
NA.7: 3 residues within 4Å:- Chain A: M.79, Y.438, E.441
Ligand excluded by PLIPNA.16: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPNA.25: 3 residues within 4Å:- Chain B: M.79, Y.438, E.441
Ligand excluded by PLIPNA.34: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPNA.43: 3 residues within 4Å:- Chain C: M.79, Y.438, E.441
Ligand excluded by PLIPNA.52: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPNA.61: 3 residues within 4Å:- Chain D: M.79, Y.438, E.441
Ligand excluded by PLIPNA.70: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPNA.79: 3 residues within 4Å:- Chain E: M.79, Y.438, E.441
Ligand excluded by PLIPNA.88: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPNA.97: 3 residues within 4Å:- Chain F: M.79, Y.438, E.441
Ligand excluded by PLIPNA.106: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPNA.115: 3 residues within 4Å:- Chain G: M.79, Y.438, E.441
Ligand excluded by PLIPNA.124: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPNA.133: 3 residues within 4Å:- Chain H: M.79, Y.438, E.441
Ligand excluded by PLIPNA.142: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIP- 8 x K: POTASSIUM ION(Non-covalent)
K.8: 3 residues within 4Å:- Chain A: F.523
- Chain D: F.523
- Ligands: K.62
No protein-ligand interaction detected (PLIP)K.26: 3 residues within 4Å:- Chain B: F.523
- Chain C: F.523
- Ligands: K.44
No protein-ligand interaction detected (PLIP)K.44: 3 residues within 4Å:- Chain B: F.523
- Chain C: F.523
- Ligands: K.26
No protein-ligand interaction detected (PLIP)K.62: 3 residues within 4Å:- Chain A: F.523
- Chain D: F.523
- Ligands: K.8
No protein-ligand interaction detected (PLIP)K.80: 3 residues within 4Å:- Chain E: F.523
- Chain H: F.523
- Ligands: K.134
No protein-ligand interaction detected (PLIP)K.98: 3 residues within 4Å:- Chain F: F.523
- Chain G: F.523
- Ligands: K.116
No protein-ligand interaction detected (PLIP)K.116: 3 residues within 4Å:- Chain F: F.523
- Chain G: F.523
- Ligands: K.98
No protein-ligand interaction detected (PLIP)K.134: 3 residues within 4Å:- Chain E: F.523
- Chain H: F.523
- Ligands: K.80
No protein-ligand interaction detected (PLIP)- 16 x CA: CALCIUM ION(Non-covalent)
CA.9: 1 residues within 4Å:- Chain A: V.286
No protein-ligand interaction detected (PLIP)CA.17: 1 residues within 4Å:- Chain A: N.83
No protein-ligand interaction detected (PLIP)CA.27: 1 residues within 4Å:- Chain B: V.286
No protein-ligand interaction detected (PLIP)CA.35: 1 residues within 4Å:- Chain B: N.83
No protein-ligand interaction detected (PLIP)CA.45: 1 residues within 4Å:- Chain C: V.286
No protein-ligand interaction detected (PLIP)CA.53: 1 residues within 4Å:- Chain C: N.83
No protein-ligand interaction detected (PLIP)CA.63: 1 residues within 4Å:- Chain D: V.286
No protein-ligand interaction detected (PLIP)CA.71: 1 residues within 4Å:- Chain D: N.83
No protein-ligand interaction detected (PLIP)CA.81: 1 residues within 4Å:- Chain E: V.286
No protein-ligand interaction detected (PLIP)CA.89: 1 residues within 4Å:- Chain E: N.83
No protein-ligand interaction detected (PLIP)CA.99: 1 residues within 4Å:- Chain F: V.286
No protein-ligand interaction detected (PLIP)CA.107: 1 residues within 4Å:- Chain F: N.83
No protein-ligand interaction detected (PLIP)CA.117: 1 residues within 4Å:- Chain G: V.286
No protein-ligand interaction detected (PLIP)CA.125: 1 residues within 4Å:- Chain G: N.83
No protein-ligand interaction detected (PLIP)CA.135: 1 residues within 4Å:- Chain H: V.286
No protein-ligand interaction detected (PLIP)CA.143: 1 residues within 4Å:- Chain H: N.83
No protein-ligand interaction detected (PLIP)- 16 x CL: CHLORIDE ION(Non-functional Binders)
CL.10: 2 residues within 4Å:- Chain A: R.345, Q.349
Ligand excluded by PLIPCL.11: 1 residues within 4Å:- Chain A: T.510
Ligand excluded by PLIPCL.28: 2 residues within 4Å:- Chain B: R.345, Q.349
Ligand excluded by PLIPCL.29: 1 residues within 4Å:- Chain B: T.510
Ligand excluded by PLIPCL.46: 2 residues within 4Å:- Chain C: R.345, Q.349
Ligand excluded by PLIPCL.47: 1 residues within 4Å:- Chain C: T.510
Ligand excluded by PLIPCL.64: 2 residues within 4Å:- Chain D: R.345, Q.349
Ligand excluded by PLIPCL.65: 1 residues within 4Å:- Chain D: T.510
Ligand excluded by PLIPCL.82: 2 residues within 4Å:- Chain E: R.345, Q.349
Ligand excluded by PLIPCL.83: 1 residues within 4Å:- Chain E: T.510
Ligand excluded by PLIPCL.100: 2 residues within 4Å:- Chain F: R.345, Q.349
Ligand excluded by PLIPCL.101: 1 residues within 4Å:- Chain F: T.510
Ligand excluded by PLIPCL.118: 2 residues within 4Å:- Chain G: R.345, Q.349
Ligand excluded by PLIPCL.119: 1 residues within 4Å:- Chain G: T.510
Ligand excluded by PLIPCL.136: 2 residues within 4Å:- Chain H: R.345, Q.349
Ligand excluded by PLIPCL.137: 1 residues within 4Å:- Chain H: T.510
Ligand excluded by PLIP- 32 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.12: 3 residues within 4Å:- Chain A: N.104, N.186, K.188
Ligand excluded by PLIPNAG.13: 2 residues within 4Å:- Chain A: R.12, N.55
Ligand excluded by PLIPNAG.14: 5 residues within 4Å:- Chain A: I.460, R.463, K.467, E.480, N.483
Ligand excluded by PLIPNAG.15: 1 residues within 4Å:- Chain A: N.254
Ligand excluded by PLIPNAG.30: 3 residues within 4Å:- Chain B: N.104, N.186, K.188
Ligand excluded by PLIPNAG.31: 2 residues within 4Å:- Chain B: R.12, N.55
Ligand excluded by PLIPNAG.32: 5 residues within 4Å:- Chain B: I.460, R.463, K.467, E.480, N.483
Ligand excluded by PLIPNAG.33: 1 residues within 4Å:- Chain B: N.254
Ligand excluded by PLIPNAG.48: 3 residues within 4Å:- Chain C: N.104, N.186, K.188
Ligand excluded by PLIPNAG.49: 2 residues within 4Å:- Chain C: R.12, N.55
Ligand excluded by PLIPNAG.50: 5 residues within 4Å:- Chain C: I.460, R.463, K.467, E.480, N.483
Ligand excluded by PLIPNAG.51: 1 residues within 4Å:- Chain C: N.254
Ligand excluded by PLIPNAG.66: 3 residues within 4Å:- Chain D: N.104, N.186, K.188
Ligand excluded by PLIPNAG.67: 2 residues within 4Å:- Chain D: R.12, N.55
Ligand excluded by PLIPNAG.68: 5 residues within 4Å:- Chain D: I.460, R.463, K.467, E.480, N.483
Ligand excluded by PLIPNAG.69: 1 residues within 4Å:- Chain D: N.254
Ligand excluded by PLIPNAG.84: 3 residues within 4Å:- Chain E: N.104, N.186, K.188
Ligand excluded by PLIPNAG.85: 2 residues within 4Å:- Chain E: R.12, N.55
Ligand excluded by PLIPNAG.86: 5 residues within 4Å:- Chain E: I.460, R.463, K.467, E.480, N.483
Ligand excluded by PLIPNAG.87: 1 residues within 4Å:- Chain E: N.254
Ligand excluded by PLIPNAG.102: 3 residues within 4Å:- Chain F: N.104, N.186, K.188
Ligand excluded by PLIPNAG.103: 2 residues within 4Å:- Chain F: R.12, N.55
Ligand excluded by PLIPNAG.104: 5 residues within 4Å:- Chain F: I.460, R.463, K.467, E.480, N.483
Ligand excluded by PLIPNAG.105: 1 residues within 4Å:- Chain F: N.254
Ligand excluded by PLIPNAG.120: 3 residues within 4Å:- Chain G: N.104, N.186, K.188
Ligand excluded by PLIPNAG.121: 2 residues within 4Å:- Chain G: R.12, N.55
Ligand excluded by PLIPNAG.122: 5 residues within 4Å:- Chain G: I.460, R.463, K.467, E.480, N.483
Ligand excluded by PLIPNAG.123: 1 residues within 4Å:- Chain G: N.254
Ligand excluded by PLIPNAG.138: 3 residues within 4Å:- Chain H: N.104, N.186, K.188
Ligand excluded by PLIPNAG.139: 2 residues within 4Å:- Chain H: R.12, N.55
Ligand excluded by PLIPNAG.140: 5 residues within 4Å:- Chain H: I.460, R.463, K.467, E.480, N.483
Ligand excluded by PLIPNAG.141: 1 residues within 4Å:- Chain H: N.254
Ligand excluded by PLIP- 8 x MG: MAGNESIUM ION(Non-functional Binders)
MG.18: 1 residues within 4Å:- Ligands: VX.4
No protein-ligand interaction detected (PLIP)MG.36: 1 residues within 4Å:- Ligands: VX.22
No protein-ligand interaction detected (PLIP)MG.54: 1 residues within 4Å:- Ligands: VX.40
No protein-ligand interaction detected (PLIP)MG.72: 1 residues within 4Å:- Ligands: VX.58
No protein-ligand interaction detected (PLIP)MG.90: 1 residues within 4Å:- Ligands: VX.76
No protein-ligand interaction detected (PLIP)MG.108: 1 residues within 4Å:- Ligands: VX.94
No protein-ligand interaction detected (PLIP)MG.126: 1 residues within 4Å:- Ligands: VX.112
No protein-ligand interaction detected (PLIP)MG.144: 1 residues within 4Å:- Ligands: VX.130
No protein-ligand interaction detected (PLIP)- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wandhammer, M. et al., Structural Study of the Complex Stereoselectivity of Human Butyrylcholinesterase for the Neurotoxic V-Agents. J.Biol.Chem. (2011)
- Release Date
- 2011-03-23
- Peptides
- CHOLINESTERASE: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
AG
AH
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.40 Å
- Oligo State
- homo-octamer
- Ligands
- 16 x NAG- NAG- FUL: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[beta-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 8 x GLY: GLYCINE(Non-covalent)
- 8 x VX: O-ETHYLMETHYLPHOSPHONIC ACID ESTER GROUP(Covalent)
- 16 x SO4: SULFATE ION(Non-functional Binders)
- 16 x NA: SODIUM ION(Non-functional Binders)
- 8 x K: POTASSIUM ION(Non-covalent)
- 16 x CA: CALCIUM ION(Non-covalent)
- 16 x CL: CHLORIDE ION(Non-functional Binders)
- 32 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 8 x MG: MAGNESIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wandhammer, M. et al., Structural Study of the Complex Stereoselectivity of Human Butyrylcholinesterase for the Neurotoxic V-Agents. J.Biol.Chem. (2011)
- Release Date
- 2011-03-23
- Peptides
- CHOLINESTERASE: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
AG
AH
A